← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2002Last known activity
Jun 1, 2014
Acquired by Achieve Life Sciences on Aug 1, 2017
Timeline
1990s
- Jan 1, 1991
OncoGenex Technologies— Founded
2010s
- Aug 1, 2017
Achieve Life Sciences— Acquired By
Drugs by trial phase (15 distinct, 24 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Transitional Cell
- Colorectal Neoplasms
- Lung Neoplasms
- Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pelvic Neoplasms
- Prostatic Neoplasms
- Ureteral Neoplasms
- Urethral Neoplasms
- Urinary Bladder Neoplasms
- Urologic Neoplasms
Recent trials (24)
- NCT02423590CollaboratorPhase 2Jun 1, 2014
- NCT01844817CollaboratorPhase 2Sep 1, 2013
- NCT01829113CollaboratorPhase 2Jul 1, 2013
- NCT01874561Lead sponsorPhase 1May 1, 2013
- NCT01780545CollaboratorPhase 2Apr 1, 2013
- NCT01681433CollaboratorPhase 2Dec 1, 2012
- NCT01630733Lead sponsorPhase 3Sep 1, 2012
- NCT01578655Lead sponsorPhase 3Aug 1, 2012
- NCT01497470Lead sponsorPhase 1Apr 1, 2012
- NCT01454089Lead sponsorPhase 2Oct 1, 2011
- NCT01188187Lead sponsorPhase 3Nov 1, 2010
- NCT01120470CollaboratorPhase 2Sep 1, 2010
- NCT01083615Lead sponsorPhase 3Mar 1, 2010
- NCT00487786Lead sponsorPhase 1Jun 1, 2007
- NCT00385177Lead sponsorPhase 1Sep 1, 2006
Details
- Founded
- Bothell, WA, US Jan 1, 1991
- Last known activity
- Jun 1, 2014